Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1800685 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
α1B-adrenoceptor/Alpha-1b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL232] [GtoPdb: 23] [UniProtKB: P35368] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Alpha1B | B | 5.49 | pKi | 3235.94 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Alpha1B | B | 5.49 | pKi | 3230.73 | nM | Ki | Data for DCP probe PPTN |
α2A-adrenoceptor/Alpha-2a adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1867] [GtoPdb: 25] [UniProtKB: P08913] | ||||||||
ChEMBL | Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay | B | 5.82 | pKi | 1530 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay | B | 5.39 | pIC50 | 4070 | nM | IC50 | Data for DCP probe PPTN |
α2B-adrenoceptor/Alpha-2b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1942] [GtoPdb: 26] [UniProtKB: P18089] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Alpha2B | B | 5.59 | pKi | 2570.4 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Alpha2B | B | 5.59 | pKi | 2561.53 | nM | Ki | Data for DCP probe PPTN |
α2C-adrenoceptor/Alpha-2c adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1916] [GtoPdb: 27] [UniProtKB: P18825] | ||||||||
ChEMBL | Adrenergic alpha2C Eurofins-Panlabs radioligand binding assay | B | 6 | pKi | 1000 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Adrenergic alpha2C Eurofins-Panlabs radioligand binding assay | B | 5.16 | pIC50 | 6880 | nM | IC50 | Data for DCP probe PPTN |
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945] | ||||||||
ChEMBL | Inhibition of Adrenergic beta3 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204200) | B | 5.14 | pKi | 7200 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Beta3 | B | 5.53 | pKi | 2951.21 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Beta3 | B | 5.53 | pKi | 2918.77 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Adrenergic beta3 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204200) | B | 5.02 | pIC50 | 9610 | nM | IC50 | Data for DCP probe PPTN |
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
ChEMBL | Agonist activity at CB1 receptor (unknown origin) | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Antagonist activity at CB1 receptor (unknown origin) | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
CB1 receptor/Cannabinoid CB1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272] | ||||||||
ChEMBL | Antagonist activity at rat brain CB2 receptor expressed in HEK-Flp-In cells in presence of [3H]CP55940 measured after overnight incubation by Bright-Glo luminescence assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1281-1286 [PMID:32551012] |
ChEMBL | Antagonist activity at rat brain CB1 receptor expressed in HEK-Flp-In cells in presence of [3H]CP55940 measured after overnight incubation by Bright-Glo luminescence assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1281-1286 [PMID:32551012] |
CB2 receptor/Cannabinoid CB2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
ChEMBL | Agonist activity at CB2 receptor (unknown origin) | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Antagonist activity at CB2 receptor (unknown origin) | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of Cyclooxygenase COX-2 at 10 µM in the Eurofins-Panlabs enzyme assay (Eurofins_assay_118010) | B | 5.06 | pIC50 | 8710 | nM | IC50 | Data for DCP probe PPTN |
CysLT1 receptor/Cysteinyl leukotriene receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1798] [GtoPdb: 269] [UniProtKB: Q9Y271] | ||||||||
ChEMBL | Inhibition of Leukotriene, Cysteinyl CysLT1 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_250460) | B | 6.64 | pKi | 230 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Leukotriene, Cysteinyl CysLT1 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_250460) | B | 6.25 | pIC50 | 560 | nM | IC50 | Data for DCP probe PPTN |
δ receptor/Delta opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143] | ||||||||
ChEMBL | Binding affinity to human delta opioid receptor expressed in HEK cells by PDSP assay | B | 5.56 | pKi | 2750 | nM | Ki | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Binding affinity to DOR (unknown origin) | B | 5.56 | pKi | 2750 | nM | Ki | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
ChEMBL | GPCRScan assay: inhibition of D1 | B | 5 | pKi | 10000 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of D1 | B | 5 | pKi | 10000 | nM | Ki | Data for DCP probe PPTN |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Binding affinity to DRD3 (unknown origin) | B | 5.17 | pKi | 6790 | nM | Ki | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Inhibition of Dopamine D3 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_219800) | B | 5.57 | pKi | 2700 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of D3 | B | 6.05 | pKi | 891.25 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of D3 | B | 6.05 | pKi | 884.3 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Dopamine D3 at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_219800) | B | 5.1 | pIC50 | 7940 | nM | IC50 | Data for DCP probe PPTN |
D3 receptor/Dopamine D3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020] | ||||||||
ChEMBL | Binding affinity to rat D3 dopamine receptor expressed in HEK293T cells by PDSP assay | B | 5.17 | pKi | 6790 | nM | Ki | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
D5 receptor/Dopamine D5 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1850] [GtoPdb: 218] [UniProtKB: P21918] | ||||||||
ChEMBL | GPCRScan assay: inhibition of D5 | B | 5.55 | pKi | 2819.68 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of D5 | B | 5.55 | pKi | 2818.38 | nM | Ki | Data for DCP probe PPTN |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | Inhibition of Transporter, Dopamine (DAT) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_220320) | B | 5.74 | pKi | 1830 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Transporter, Dopamine (DAT) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_220320) | B | 5.64 | pIC50 | 2310 | nM | IC50 | Data for DCP probe PPTN |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of full length human ERG expressed in CHO cells by patch-clamp method | B | 4.52 | pEC50 | >30000 | nM | EC50 | J Med Chem (2021) 64: 5099-5122 [PMID:33787273] |
κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145] | ||||||||
ChEMBL | Inhibition of Opiate kappa (OP2, KOP) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260210) | B | 5.49 | pKi | 3210 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Opiate kappa (OP2, KOP) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260210) | B | 5.1 | pIC50 | 8030 | nM | IC50 | Data for DCP probe PPTN |
mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
ChEMBL | NanoBRET (SGC Frankfurt) (MAPK14) | B | 4.7 | pIC50 | >20000 | nM | IC50 | Data for DCP probe PPTN |
NTS1 receptor/Neurotensin receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989] | ||||||||
ChEMBL | Neurotensin NT1 Eurofins-Panlabs radioligand binding assay | B | 5.16 | pKi | 6970 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Neurotensin NT1 Eurofins-Panlabs radioligand binding assay | B | 5.06 | pIC50 | 8660 | nM | IC50 | Data for DCP probe PPTN |
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
ChEMBL | Inhibition of Transporter, Norepinephrine (NET) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204410) | B | 5.49 | pKi | 3270 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Transporter, Norepinephrine (NET) at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204410) | B | 5.48 | pIC50 | 3300 | nM | IC50 | Data for DCP probe PPTN |
P2Y14 receptor in Human [GtoPdb: 330] [UniProtKB: Q15391] | ||||||||
GtoPdb | - | - | 10.1 | pKi | 0.43 | nM | KB | Mol Pharmacol (2013) 84: 41-9 [PMID:23592514] |
P2Y14 receptor/P2Y purinoceptor 14 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1770046] [GtoPdb: 330] [UniProtKB: Q9ESG6] | ||||||||
ChEMBL | Inhibition of mouse P2Y14 receptor in presence of 2% HSA | B | 7.46 | pKi | 35 | nM | Ki | Eur J Med Chem (2019) 175: 34-39 [PMID:31071548] |
ChEMBL | Displacement of Alexafluor488 labeled 4-(4-(1-(4-(1-(6-(4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-3-carboxybenzamido)hexyl)-1H-1,2,3-triazol-4-yl)butyl)piperidin-4-yl)phenyl)-7-(4-(trifluoromethyl)phenyl)-2-naphthoic acid from HA-tagged mouse P2Y14 expressed in HEK293 cells measured after 30 mins by FACScalibur flow cytometry analysis | B | 7.67 | pIC50 | 21.6 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1281-1286 [PMID:32551012] |
ChEMBL | Inhibition of MRS4174 binding to mouse P2Y14R expressed in HEK293 cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 30 mins by flow cytomtery based competitive fluorescence assay | B | 7.67 | pIC50 | 21.6 | nM | IC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
P2Y14 receptor/P2Y purinoceptor 14 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295660] [GtoPdb: 330] [UniProtKB: O35881] | ||||||||
ChEMBL | Antagonist activity at P2Y14R in rat C6 cells assessed as suppression of UDP-glucose-mediated inhibition of forskolin-stimulated [3H]cyclic-AMP accumulation after 15 mins in presence of [3H]-adenine | B | 9.4 | pKi | 0.4 | nM | Ki | J Med Chem (2018) 61: 4860-4882 [PMID:29767967] |
phosphodiesterase 2A/Phosphodiesterase 2A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2652] [GtoPdb: 1297] [UniProtKB: O00408] | ||||||||
ChEMBL | Phosphodiesterase PDE2 Eurofins-Panlabs enzyme assay | B | 4.06 | pIC50 | 86900 | nM | IC50 | Data for DCP probe PPTN |
phosphodiesterase 5A/Phosphodiesterase 5A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1827] [GtoPdb: 1304] [UniProtKB: O76074] | ||||||||
ChEMBL | Inhibition of Phosphodiesterase PDE5 at 10 µM in the Eurofins-Panlabs enzyme assay (Eurofins_assay_156000) | B | 4.42 | pIC50 | 38200 | nM | IC50 | Data for DCP probe PPTN |
EP3 receptor/Prostanoid EP3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3710] [GtoPdb: 342] [UniProtKB: P43115] | ||||||||
ChEMBL | Prostanoid EP3 Eurofins-Panlabs radioligand binding assay | B | 5.03 | pIC50 | 9270 | nM | IC50 | Data for DCP probe PPTN |
P2Y1 receptor/Purinergic receptor P2Y1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4315] [GtoPdb: 323] [UniProtKB: P47900] | ||||||||
ChEMBL | Antagonist activity human P2Y1R expressed in human 1321N1 cells assessed as inhibition of 2MeSADP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y1R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y11 receptor/Purinergic receptor P2Y11 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4867] [GtoPdb: 327] [UniProtKB: Q96G91] | ||||||||
ChEMBL | Antagonist activity human P2Y11R expressed in human 1321N1 cells assessed as inhibition of ATP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y11R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y12 receptor/Purinergic receptor P2Y12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2001] [GtoPdb: 328] [UniProtKB: Q9H244] | ||||||||
ChEMBL | Antagonist activity at P2Y12R (unknown origin) expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y14 receptor/Purinergic receptor P2Y14 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4518] [GtoPdb: 330] [UniProtKB: Q15391] | ||||||||
ChEMBL | Binding assay with 2% HSA | B | 7.46 | pKi | 35 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Binding assay (no HSA) | B | 8.64 | pKi | 2.3 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Antagonist activity at human P2Y14 expressed in CHO cells assessed as inhibition of forskolin-induced increase of cAMP accumulation incubated for 15 mins in presence of IBMX | F | 9.37 | pKi | 0.43 | nM | Ki | J Med Chem (2022) 65: 3434-3459 [PMID:35113556] |
ChEMBL | Antagonist activity at human P2Y14R stably expressed in rat C6 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by measuring inhibition constant incubated for 15 mins in presence of IBMX by chromatography | F | 9.37 | pKi | 0.43 | nM | Ki | J Med Chem (2023) 66: 9076-9094 [PMID:37382926] |
GtoPdb | - | - | 10.1 | pKi | 0.43 | nM | KB | Mol Pharmacol (2013) 84: 41-9 [PMID:23592514] |
ChEMBL | Inhibition of MRS4174 binding to human P2Y14R expressed in CHO cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 30 mins at pH 6 by flow cytomtery based competitive fluorescence assay | B | 7.72 | pIC50 | 19 | nM | IC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Inhibition of MRS4174 binding to human P2Y14R expressed in CHO cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 30 mins at pH 6.5 by flow cytomtery based competitive fluorescence assay | B | 7.84 | pIC50 | 14.5 | nM | IC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Inhibition of MRS4174 binding to human P2Y14R expressed in CHO cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 30 mins at pH 7 by flow cytomtery based competitive fluorescence assay | B | 8.01 | pIC50 | 9.75 | nM | IC50 | J Med Chem (2020) 63: 9563-9589 [PMID:32787142] |
ChEMBL | Inhibition of fluorescent antagonist binding to human P2Y14 expressed in CHO cells incubated for 30 mins | B | 8.1 | pIC50 | 8 | nM | IC50 | J Med Chem (2022) 65: 3434-3459 [PMID:35113556] |
ChEMBL | Displacement of MRS4174 from human P2Y14R expressed in CHO cells preincubated for 30 mins followed by MRS4174 addition measured after 30 mins by flow cytometric method | B | 8.1 | pIC50 | 7.96 | nM | IC50 | J Med Chem (2018) 61: 4860-4882 [PMID:29767967] |
ChEMBL | Displacement of 6-Amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)-naphthalen-1-yl)phenyl)piperidin-1-yl)-butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)-phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate from human P2Y14R expressed in CHO cells measured after 15 mins by flow cytometric analysis | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Displacement of Alexafluor488 labeled 4-(4-(1-(4-(1-(6-(4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-3-carboxybenzamido)hexyl)-1H-1,2,3-triazol-4-yl)butyl)piperidin-4-yl)phenyl)-7-(4-(trifluoromethyl)phenyl)-2-naphthoic acid from human P2Y14 expressed in CHO cells measured after 30 mins by FACScalibur flow cytometry analysis | B | 8.22 | pIC50 | 6 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1281-1286 [PMID:32551012] |
ChEMBL | Antagonist activity at human P2Y14R stably expressed in human forskolin treated THP1 cells assessed as reduction in P2Y14R agonist UDPG-induced inhibition of cAMP production incubated for 15 mins by competitive enzyme-linked immunoassay | F | 8.7 | pIC50 | 1.98 | nM | IC50 | Eur J Med Chem (2019) 181: 111564-111564 [PMID:31376563] |
ChEMBL | Antagonist activity at P2Y14R (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated in presence of IBMX by cAMP-glo assay | F | 8.7 | pIC50 | 1.98 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
ChEMBL | Antagonist activity at P2Y14 (unknown origin) expressed in HEK293 cells assessed as reduction in cAMP production incubated for 30 mins by ADP-glo assay | F | 8.7 | pIC50 | 1.98 | nM | IC50 | Eur J Med Chem (2021) 216: 113313-113313 [PMID:33667846] |
ChEMBL | FLIPR assay | B | 9.3 | pIC50 | 0.5 | nM | IC50 | Data for DCP probe PPTN |
ChEMBL | Antagonist activity human P2Y14R expressed in African green monkey COS7 cells assessed as inhibition of UDPG-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 9.4 | pIC50 | 0.4 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y14R (unknown origin) expressed in rat C6 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 9.4 | pIC50 | 0.4 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y2 receptor/Purinergic receptor P2Y2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4398] [GtoPdb: 324] [UniProtKB: P41231] | ||||||||
ChEMBL | Antagonist activity human P2Y2R expressed in human 1321N1 cells assessed as inhibition of UTP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y2R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y4 receptor/Pyrimidinergic receptor P2Y4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2123] [GtoPdb: 325] [UniProtKB: P51582] | ||||||||
ChEMBL | Antagonist activity human P2Y4R expressed in human 1321N1 cells assessed as inhibition of UTP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y4R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
P2Y6 receptor/Pyrimidinergic receptor P2Y6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4714] [GtoPdb: 326] [UniProtKB: Q15077] | ||||||||
ChEMBL | Antagonist activity human P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 6149-6168 [PMID:27331270] |
ChEMBL | Antagonist activity at P2Y6R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 15967-15990 [PMID:36394994] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
ChEMBL | Inhibition of Serotonin (5-Hydroxytryptamine) 5-HT1A at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_271110) | B | 5.4 | pKi | 4000 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Inhibition of Serotonin (5-Hydroxytryptamine) 5-HT1A at 10 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_271110) | B | 5.15 | pIC50 | 7010 | nM | IC50 | Data for DCP probe PPTN |
σ2/Sigma intracellular receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105907] [GtoPdb: 2553] [UniProtKB: Q5BJF2] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 5.95 | pKi | 1122.02 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 5.95 | pKi | 1120.99 | nM | Ki | Data for DCP probe PPTN |
sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL287] [GtoPdb: 2552] [UniProtKB: Q99720] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Sigma 1 | B | 5.93 | pKi | 1180.59 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | GPCRScan assay: inhibition of Sigma 1 | B | 5.93 | pKi | 1174.9 | nM | Ki | Data for DCP probe PPTN |
SST4 receptor/Somatostatin receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1853] [GtoPdb: 358] [UniProtKB: P31391] | ||||||||
ChEMBL | Somatostatin sst4 Eurofins-Panlabs radioligand binding assay | B | 5.28 | pIC50 | 5300 | nM | IC50 | Data for DCP probe PPTN |
Vesicular monoamine transporter 2/Synaptic vesicular amine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1893] [GtoPdb: 1012] [UniProtKB: Q05940] | ||||||||
ChEMBL | Transporter, Monoamine Eurofins-Panlabs radioligand binding assay | B | 5.51 | pKi | 3090 | nM | Ki | Data for DCP probe PPTN |
ChEMBL | Transporter, Monoamine Eurofins-Panlabs radioligand binding assay | B | 5.43 | pIC50 | 3720 | nM | IC50 | Data for DCP probe PPTN |
Uncharacterized protein in Pan troglodytes (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3831325] [UniProtKB: A0A2J8P2M1] | ||||||||
ChEMBL | Antagonist activity against chimpanzee GPR105 expressed in stable HEK cells co-expressing chimeric G-protein Gqi5 assessed as inhibition of UDP-glucose-induced Ca2+ signaling response incubated for 20 mins by FLIPR assay | F | 8.66 | pIC50 | 2.2 | nM | IC50 | US-20100298347-A1. Substituted 2-naphthoic acids as antagonists of gpr105 activity (2010) |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]